Patients will be able to find out whether they have genes linked to cancer using a world-leading tool developed by the NHS.

@hopkinskimmel researchers develop novel liquid biopsy approach to identifying early-stage cancers. › ...

Despite major advances in genetic testing for breast cancer risk prediction, death rates remain disproportionately high among ...

An emerging oncology tool known as broad genomic profiling or BGP is increasingly being used to help identify targeted therapies for patients diagnosed with cancer. Rather than analyzing one gene at a ...

In 2023, Jill Martin took a test that changed her life. She underwent genetic testing for breast cancer and learned she had a BRCA2 mutation, which increases one’s risk of developing breast and other ...

We are at a transformative moment in oncology. Remarkable advancements have led to the identification of biomarkers that can predict treatment response, tests that can detect cancer risk before ...

The landscape of metastatic prostate cancer (mPCa) treatment has evolved significantly with the advent of targeted therapies, particularly poly (ADP-ribose) polymerase inhibitors (PARPis). 1 However, ...

Do microorganisms truly reside in tumors, or do the samples become contaminated before sequencing occurs? A new computational ...

Precision medicine in prostate cancer utilizes genetic testing to identify patients for PARP inhibitor treatment, enhancing personalized care. Genetic testing, including germline and somatic, is ...

From rare cancers caught early to dementia foretold decades in advance, newborn genomic testing raises an unsettling question ...

They include the “Jolie” gene, named after actress Angelina Jolie, who had preventative surgery after finding out she had a genetically heightened risk of breast and ovarian cancers.